Cardinal Health to Buy J&J's Heart Business for $1.94B

Cardinal Health Inc. agreed to acquire the heart-product business from Johnson & Johnson for $1.94 billion in cash, in a move aimed at strengthening its cardiology efforts.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.